Granules India receives USFDA approval for Amphetamine

Granules India has received USFDA approval for a generic central nervous system stimulant drug- Amphetamine Sulfate tablets. The prescribed drug will be produced in strengths of 5 mg and 10 mg.

The product is a generic version of Arbor Pharmaceuticals LLC’s Evekeo tablets in similar strength. It is used as a central nervous system stimulant to treat sleep disorder, increase attention, decrease impulsiveness and hyperactivity in patients with Attention Deficit Hyperactivity Disorder (ADHD).

Company Profile : Granules India Ltd

Be the first to comment

Leave a Reply

Your email address will not be published.


*